Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases - 02/01/22
Doi : 10.1016/j.jbspin.2021.105253
Pascal Richette a, b, ⁎ 
, Matthieu Allez c, Vincent Descamps d, Lucas Perray e, Simon Pilet e, Augustin Latourte a, b, Milka Maravic e
, Matthieu Allez c, Vincent Descamps d, Lucas Perray e, Simon Pilet e, Augustin Latourte a, b, Milka Maravic e a Rheumatology department, Lariboisière Hospital, AP–HP, 2, rue Ambroise Paré, 75010 Paris, France
b Inserm U1132, Paris University, Paris, France
c Gastro Enterology department, St-Louis Hospital, AP–HP, Paris, France
d Dermatology department, Bichat Hospital, AP–HP, Paris, France
e IQVIA, La Défense, France
⁎Corresponding author at: Rheumatology department, Lariboisière Hospital, AP–HP, 2, rue Ambroise Paré, 75010 Paris, France.Rheumatology department, Lariboisière Hospital, AP–HP2, rue Ambroise ParéParis75010France
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Keywords : COVID-19, Biologics, Treatment
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2021
Pubblicato da Elsevier Masson SAS.
Vol 89 - N° 1
Articolo 105253- Gennaio 2022 Ritorno al numero
Articolo precedente
- Physical activity and rheumatoid arthritis: Need for practical, precise, and personalized support–Results from an online survey
- Anne-Christine Rat, Arnaud Constantin, Catherine Beauvais, Yannick Guillodo, Valérie Guay, Emilie Pain, Lise Radoszycki, Florence Levy-Weil
- The negative impact of depression in women with Axial Spondyloarthropathy
- Sinead Maguire, Phil Gallagher, Finbar O'Shea
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.